Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Mediclinic International    MDC   GB00B8HX8Z88

MEDICLINIC INTERNATIONAL (MDC)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Mediclinic International : Emirati double amputee gets 3D printed prosthetics

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/13/2018 | 04:40pm CEST

Under the patronage of Dubai Health Authority (DHA) and in partnership with Mediclinic, Mercuris and Immensa Technology Labs, an Emirati double amputee recently became the first to receive 3D printed transtibial prosthetics.

The department of humanitarian services at the DHA fully supported and funded the initiative.

The 25-year-old year old Emirati a Paralympic champion was able to walk with the maximum feeling of anatomical function due to his 3D prosthetics.

Humaid Al Qutami, director-general of the Dubai Health Authority, said: "The DHA has prioritised fostering the development of future technologies such as 3D printing in healthcare to provide high-quality patient-centric care. We are keen to use this technology in the health sector to improve efficiencies, enhance healthcare management, improve overall workflows and most importantly further improve patient care. This is truly heartening as it is an example of how healthcare technology directly improves the patient's quality of life. We aim to continue harnessing manpower, collaborating and investing in future health technologies to serve our community."

Dr Mohammad Al Redha, the Director of the Executive Office for Organisational Transformation at DHA, said, "This is a unique collaboration that allows us to see the most modern technology develop and become a reality. Our aim at the DHA is to provide patients with the best possible care and thus we are happy to bring together international and local stakeholders to work jointly on future technologies. The work we have done so far is part of the foundation of future 3D printing research and development work in the UAE.

Sebastian Giede, certified orthopaedic prosthetist with Mediclinic, said, "The potential of 3D printing in the field of prosthetic devices is huge. It allows for faster turnaround times, we can get a foot customized within two to three weeks, it provides more personalisation in terms of both design and functionality, as well as great flexibility when it comes to replacement. The functionality of 3D printed prosthetics is superior as it allows us to design completely individualised models as compared to mass manufactured prosthetics."

Giede added that every aspect including the colour can be individualised.

In terms of the process of designing the 3D prosthetics, Giede, said, "We conducted several 3D scans of the patient's amputated legs. After that, we used a CAD software program to design and modify the inner shape of the prosthesis. Then the test socket was 3D printed so that we could use it on the patient to control the size and make changes that will help provide the patient with maximum comfort and functional alignment."

A Dubai-based company known as Immensa Technology Labs provided the test socket and final socket, which is about 40 per cent of the 3D prosthetics.

Fahmi Al Shawwa, CEO of Immensa Technology Labs, said, "3D printing technology provides a massive opportunity for Dubai to become competitive across various sectors including medical and we are proud to be working with the DHA and Sebastian Giede to realise this potential. Immensa is investing heavily in developing 3D printing capabilities and knowledge in line with the 'Dubai 3D Printing Strategy' and we believe that we need to see more private sector participation and involvement to fully capitalise on this technology on a wider UAE scale."

The rest of the 3D prosthetics were provided by Mecuris, which is a company based in Germany that combines existing industrial 3D technologies like 3D scanning, 3D data processing and 3D printing into an innovative process of digital tailoring for orthopaedics.

Manuel Opitz, CEO of Mecuris GmbH Germany said: "We team up with medical professionals to co-create - with users and wearers - customised O&P products. This now is the second time we have worked together. With partners like this, boundaries are non-existent and the patient's needs and preferences are at the centre of a truly individual care, enabling us to enrich the wearer´s life."

Giede constructed the prosthetics in Dubai, he said, "We are proud that we were able to provide Fahad with 100 per cent customized 3D printed prosthetics that provides a natural feeling of anatomical movement to the maximum extent possible." - TradeArabia News Service

آ© Copyright 2014 www.tradearabia.com

(c) 2018 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDICLINIC INTERNATIONAL
08/14MEDICLINIC INTERNATIONAL : Intnl plc - Holding(s) in Company
PU
08/10MEDICLINIC INTERNATIONAL : Intnl plc - Director/PDMR Shareholding
PU
08/06Lower NHS referrals dent Spire Healthcare's profit view, shares sink
RE
07/31MEDICLINIC INTERNATIONAL : Law firm advises Majid Al Futtaim on major Mediclinic..
AQ
07/26MEDICLINIC INTERNATIONAL : Intnl plc - Result of AGM
PU
07/26MEDICLINIC INTERNATIONAL : Press Release
CO
07/26MEDICLINIC INTERNATIONAL : Proxy Statments
CO
07/25MEDICLINIC INTERNATIONAL : Intnl plc - Directorate Change
PU
07/17MEDICLINIC INTERNATIONAL : The funeral arrangements for Theo-Ben Gurirab, will b..
AQ
07/12MEDICLINIC INTERNATIONAL : Tough treatment
AQ
More news
News from SeekingAlpha
2015Anworth Mortgage Needs To Be More Aggressive For Stock To Prosper 
2015Anworth Mortgage Asset (ANH) Q4 2014 Results - Earnings Call Transcript 
2015Anworth Earns Neutral Thesis 
2015Anworth keeps up buybacks at deep discount to book 
2015Anworth Mortgage Asset beats by $0.02 
Financials (GBP)
Sales 2019 2 975 M
EBIT 2019 367 M
Net income 2019 228 M
Debt 2019 1 636 M
Yield 2019 1,76%
P/E ratio 2019 15,23
P/E ratio 2020 13,43
EV / Sales 2019 1,71x
EV / Sales 2020 1,60x
Capitalization 3 448 M
Chart MEDICLINIC INTERNATIONAL
Duration : Period :
Mediclinic International Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDICLINIC INTERNATIONAL
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 6,56  GBP
Spread / Average Target 39%
EPS Revisions
Managers
NameTitle
C. A. Ronnie van der Merwe Chief Executive Officer & Executive Director
Edwin de la Harpe Hertzog Non-Executive Chairman
Petrus Jurgens Myburgh Chief Financial Officer & Executive Director
Dirk Le Roux Chief Information Officer
Danie P. Meintjes Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDICLINIC INTERNATIONAL-27.54%4 426
FRESENIUS-0.14%41 277
BANGKOK DUSIT MEDICAL SERVICES PCL--.--%11 963
AIER EYE HOSPITAL GROUP CO LTD--.--%11 379
IHH HEALTHCARE BHD--.--%10 977
RAMSAY HEALTH CARE LIMITED-20.78%8 087